Lighthouse Investment Partners’s Sarepta Therapeutics SRPT Stock Holding History

Lighthouse Investment Partners’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2,446	Closed	-$297K	–	628
2024 Q4	$297K	Sell	2,446 -5,554	-69%	-$681K	0.01%	446
2024 Q3	$999K	Sell	8,000 -42,342	-84%	-$5.85M	0.04%	329
2024 Q2	$7.95M	Buy	+50,342	New	+$6.47M	0.32%	84
2023 Q3	–	Sell	-4,390	Closed	-$503K	–	422
2023 Q2	$503K	Buy	+4,390	New	+$566K	0.03%	244
2023 Q1	–	Sell	-10,438	Closed	-$1.35M	–	372
2022 Q4	$1.35M	Buy	+10,438	New	+$1.21M	0.15%	110

Other funds holding SRPT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Lighthouse Investment Partners's SRPT Position: Q1 2025 in Review

Lighthouse Investment Partners sold out of Sarepta Therapeutics (SRPT) in Q1 2025, closing a stake of 2,446 shares — an estimated $297K sold.

Lighthouse Investment Partners first reported a position in SRPT in Q4 2022 and held it in 5 quarters. The position peaked at $7.95M in Q2 2024. 430 funds tracked by Wall St. Rank hold SRPT as of Q1 2025.

Lighthouse Investment Partners reported no remaining Sarepta Therapeutics position as of Q1 2025 after selling out during the quarter.
Lighthouse Investment Partners sold 2,446 Sarepta Therapeutics shares in Q1 2025, an estimated $297K.
Lighthouse Investment Partners first reported a position in Sarepta Therapeutics in Q4 2022 and held it in 5 quarters.
Lighthouse Investment Partners's Sarepta Therapeutics position peaked at $7.95M in Q2 2024.
430 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q1 2025.

Based on Lighthouse Investment Partners's 13F filing for Q1 2025, filed 15 May 2025.